Related Experiment Video
Updated: May 6, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Microenvironment-a role in tumour progression and prognosis
Jaya Nagendra Krishna Muppalla1, Keerthi Muddana, Shyam Prasad Reddy Dorankula
1Senior lecturer, Department of Endodontics & Conservative Dentistry, Kamineni Institute of Dental Sciences , Narketpally, Nalgonda (dt), Andhra Pradesh, India .
Solid tumors involve cancer cells and stromal tissue, forming the tumor microenvironment. Understanding this microenvironment, including Tumor-Associated Fibroblasts (TAFs), is key to developing new cancer treatments targeting nonmutational events.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Solid tumors consist of malignant cells and a supporting stromal tissue, including the extracellular matrix (ECM), connective tissue, inflammatory cells, and blood vessels.
- The tumor microenvironment (TME), shaped by both malignant and stromal cells, critically influences cancer progression and treatment effectiveness.
- Cancer progression involves significant host microenvironment changes, including the development of Tumor-Associated Fibroblasts (TAFs).
Purpose of the Study:
- To explore the components of the tumor microenvironment and their role in cancer progression.
- To highlight the significance of Tumor-Associated Fibroblasts (TAFs) in modulating tumor growth, invasion, and cancer stem cell (CSC) phenotype.
- To identify opportunities for developing novel therapeutic strategies targeting reversible, nonmutational events within the TME.
Main Methods:
- Review and synthesis of current literature on tumor microenvironment composition and function.
- Analysis of the role of stromal components, particularly TAFs, in cancer progression.
- Investigation of the interplay between TAFs and Cancer Stem Cells (CSCs).
Main Results:
- TAFs promote tumor progression by releasing growth factors and cytokines, enhancing angiogenesis, and increasing tumor growth and invasion.
- TAFs can modulate the Cancer Stem Cell (CSC) phenotype, indicating significant therapeutic implications.
- The tumor microenvironment presents targets for novel cancer therapies aimed at nonmutational changes.
Conclusions:
- The tumor microenvironment is a complex ecosystem crucial for cancer development and progression.
- Targeting TAFs and their interactions within the TME offers a promising avenue for innovative cancer treatments.
- Understanding and targeting reversible, nonmutational aspects of the TME could lead to effective cancer prevention and therapy strategies.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Mitogens and the Cell Cycle
Microenvironments
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

